Identification, Heterologous Expression, and Characterization of the Tolypodiol Biosynthetic Gene Cluster through an Integrated Approach

Authors:

Abstract
Cyanobacteria are tremendous producers of biologically active natural products, including the potent anti-inflammatory compound tolypodiol. However, linking biosynthetic gene clusters with compound production in cyanobacteria has lagged behind that in other bacterial genera. Tolypodiol is a meroterpenoid originally isolated from the cyanobacterium HT-58-2. Here we describe the identification of the tolypodiol biosynthetic gene cluster through heterologous expression in Anabaena and in vitro protein assays of a methyltransferase found in the tolypodiol biosynthetic gene cluster. We have also identified similar biosynthetic gene clusters in cyanobacterial and actinobacterial genomes, suggesting that meroterpenoids with structural similarity to the tolypodiols may be synthesized by other microbes. We also report the identification of two new analogs of tolypodiol that we have identified in both the original and heterologous producer. This work further illustrates the usefulness of Anabaena as a heterologous expression host for cyanobacterial compounds and how integrated approaches can help to link natural product compounds with their producing biosynthetic gene clusters.
Funding Information
  • Division of Chemistry (CHE 9974921)
  • Elsa U. Pardee Foundation
  • M.J. Murdock Charitable Trust (2014162)
  • National Center for Complementary and Integrative Health (T32AT010131)
  • University of Hawai'i at Mānoa
  • National Institute on Aging (5R01AG039468)
  • U.S. Department of Energy (DE-AC02-05CH11231)
  • National Institutes of Health (S10OD018518)
  • National Institute of General Medical Sciences (R15GM117541)
  • National Science Foundation (1532310)

This publication has 55 references indexed in Scilit: